Archives
|
Entry
|
Blogger
|
Date
▴
|
Xconomist
|
Location
|
|
Voyager Capital Founders Discuss Investment Strategy, Connected Computing, and the Future of Venture Firms
|
Gregory T. Huang |
09/29/08 |
|
Seattle
|
|
In Google’s Phone, a Major Clash Between Amazon, Apple, and Microsoft Heats Up
|
Gregory T. Huang |
09/24/08 |
|
Seattle
|
|
A Good Deal for Captaris and Open Text—but Impact on Seattle-Area Innovation Is Less Clear
|
Gregory T. Huang |
09/05/08 |
|
Seattle
|
|
In Amazon’s Purchase of Shelfari, a Possible Front in the Battle with Borders—and a Triumph for Social Book Sites
|
Gregory T. Huang |
09/03/08 |
|
National
|
|
Medio in Reported Deal with Google and Verizon, Putting Seattle on the Mobile-Search Map
|
Gregory T. Huang |
08/22/08 |
|
Seattle
|
|
In Nuance’s Snapping Up of SnapIn Software, Investors Get a Better Deal—Some Further Analysis
|
Gregory T. Huang |
08/22/08 |
|
Seattle
|
|
Northwest Biotech Startups Can Get Talent and Venture Bucks, But UW Could Use Some Culture Shock, CEOs Say
|
Luke Timmerman |
07/22/08 |
|
Seattle
|
|
RXi Takes a Untraditional Route to the Public Market, Now Working To Get Pharma to Pay The Bills
|
Luke Timmerman |
07/18/08 |
|
Boston
|
|
Cortria Hires CEO Grau To Develop Heart Drugs That Won’t Make You Red in the Face
|
Luke Timmerman |
07/16/08 |
|
Boston
|
|
Lee Hood’s Proteges Strike Again: Nanostring Ships Its First Commercial Cell Analyzer
|
Luke Timmerman |
07/14/08 |
|
Seattle
|
|
Blue Heron Strives to Replace Gene-Making Grunt Work with Custom Manufacturing
|
Luke Timmerman |
06/18/08 |
|
Seattle
|
|
Gov. Patrick Travels West to Plug Massachusetts’ Life Sciences Initiative At BIO
|
Luke Timmerman |
06/16/08 |
|
Boston
|
|
Seattle Genetics Gunning for the Market With “Empowered Antibody” For Cancer
|
Luke Timmerman |
06/14/08 |
|
Seattle
|
|
Biogen Directors Win Backing From Third Advisory Firm, Icahn Could Be Heading For Defeat
|
Luke Timmerman |
06/12/08 |
|
Boston
|
|
Biogen Idec’s Nominees Win Support from Shareholder Advisory Firms
|
Luke Timmerman |
06/10/08 |
|
Boston
|
|
Do Takeover Efforts (Like Icahn’s Move on Biogen Idec) Harm Innovation?
|
Luke Timmerman |
06/10/08 |
|
Boston
|
|
Icahn Has Ideas For Biogen. Starting With More R&D Spending
|
Luke Timmerman |
06/09/08 |
|
Boston
|
|
No Quick Sale, Icahn Says in Letter to Biogen Idec Shareholders
|
Luke Timmerman |
05/28/08 |
|
Boston
|
|
EMC Soaring Into the Cloud (Computing)—the Question is When, Not If
|
Robert Buderi |
02/15/08 |
|
Boston
|
|
An Analysis of Icahn’s Biogen Idec Strategy: Why Three Board Seats When Four Will Be Open?
|
Robert Buderi |
01/31/08 |
|
Boston
|
|
Biogen Idec-Icahn Story Likely Far From Over; History Says the Activist Investor Will Act Again
|
Robert Buderi |
12/18/07 |
|
Boston
|
|
Page 1 of
1 |
|
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.
© 2007-2008 Xconomy. All rights reserved.
Site designed by
Matthew Bouchard, produced by
Andrew Koyfman,
and powered by WordPress.
